Basit öğe kaydını göster

Pembrolizumab (pembro) vs paclitaxel (PTX) for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Phase 3 KEYNOTE-061 trial.

dc.contributor.authorFornaro, Lorenzo
dc.contributor.authorFuchs, Charles S.
dc.contributor.authorBang, Yung-Jue
dc.contributor.authorDi Bartolomeo, Maria
dc.contributor.authorMandala, Mario
dc.contributor.authorRyu, Min-Hee
dc.contributor.authorOlesinski, Tomasz
dc.contributor.authorCaglevic, Christian
dc.contributor.authorChung, Hyun Cheol
dc.contributor.authorMuro, Kei
dc.contributor.authorGoekkurt, Eray
dc.contributor.authorMansoor, Wasat
dc.contributor.authorMcDermott, Raymond S.
dc.contributor.authorShacham-Shmueli, Einat
dc.contributor.authorChen, Xinqun
dc.contributor.authorKang, S. Peter
dc.contributor.authorMayo, Carlos Alberto
dc.contributor.authorOhtsu, Atsushi
dc.contributor.authorShitara, Kohei
dc.contributor.authorOzguroglu, Mustafa
dc.date.accessioned2021-03-05T10:11:25Z
dc.date.available2021-03-05T10:11:25Z
dc.date.issued2018
dc.identifier.citationFuchs C. S. , Ozguroglu M., Bang Y., Di Bartolomeo M., Mandala M., Ryu M., Fornaro L., Olesinski T., Caglevic C., Chung H. C. , et al., "Pembrolizumab (pembro) vs paclitaxel (PTX) for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Phase 3 KEYNOTE-061 trial.", JOURNAL OF CLINICAL ONCOLOGY, cilt.36, 2018
dc.identifier.issn0732-183X
dc.identifier.othervv_1032021
dc.identifier.otherav_a1d36efb-7e8b-454b-a524-69fbf0fa6418
dc.identifier.urihttp://hdl.handle.net/20.500.12627/108410
dc.identifier.urihttps://doi.org/10.1200/jco.2018.36.15_suppl.4062
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.titlePembrolizumab (pembro) vs paclitaxel (PTX) for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Phase 3 KEYNOTE-061 trial.
dc.typeMakale
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGY
dc.contributor.department, ,
dc.identifier.volume36
dc.identifier.issue15
dc.contributor.firstauthorID253289


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster